Dr. Reddy's Laboratories Ltd.

RDY13 Dec 2024
Healthcare
$14.48
0.00 (-0.41%)
Lowest Today
$14.4
Highest Today
$14.53
Today’s Open
$14.48
Prev. Close
$14.46
52 Week High
$16.89
52 Week Low
$12.49
To Invest in Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

Healthcare
RDY13 Dec 2024
0.00 (-0.41%)
1M
3M
6M
1Y
5Y
Low
$14.4
Day’s Range
High
$14.53
14.4
52 Week Low
$12.49
52-Week Range
52 Week High
$16.89
12.49
1 Day
-
1 Week
-1.23%
1 month return
-0.82%
3 month return
-82.07%
6 month return
-80.17%
1 Year return
-78.6%
3 Years return
-76.2%
5 Years return
-64.41%
10 Years return
-
Institutional Holdings
Morgan Stanley - Brokerage Accounts
1.35
Robeco Institutional Asset Management BV
1.24
Royal Bank of Canada
1.2
Renaissance Technologies Corp
1.17
BlackRock Inc
1.08
RBC Emerging Markets Equity
0.85
RBC Emerging Markets Equity Fund F
0.85

Market Status

Fundamentals
Market Cap
12153.73 mln
PB Ratio
3.35
PE Ratio
18.54
Enterprise Value
11982.52 mln
Total Assets
387518 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Organisation
Dr. Reddy's Laboratories Ltd.
Employees
27048
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Erez  Israeli M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities